Bioequivalence of a biosimilar enoxaparin (Cloti-Xa&#8482;) and its innovator (Clexane<sup>®</sup> ): A single-dose, randomized, double-blind, two-period, two-treatment, two-sequence, crossover, balanced study in healthy human subjects.

Saxena, Sumit; Chaudhary, Manu; Chaudhary, Saransh; Aggarwal, Anmol

Bioequivalence of a biosimilar enoxaparin (Cloti-Xa™) and its innovator (Clexane^® ): A single-dose, randomized, double-blind, two-period, two-treatment, two-sequence, crossover, balanced study in healthy human subjects.

Saxena, Sumit; Chaudhary, Manu; Chaudhary, Saransh; Aggarwal, Anmol.

Afiliação

Saxena S; Venus Medicine Research Centre, Baddi, Himachal Pradesh, India.
Chaudhary M; Venus Medicine Research Centre, Baddi, Himachal Pradesh, India.
Chaudhary S; Venus Medicine Research Centre, Baddi, Himachal Pradesh, India.
Aggarwal A; Venus Medicine Research Centre, Baddi, Himachal Pradesh, India.

Pharmacol Res Perspect ; 10(4): e00979, 2022 08.

Article em En | MEDLINE | ID: mdl-35762448

Assuntos

Medicamentos Biossimilares; Enoxaparina; Medicamentos Biossimilares/efeitos adversos; Enoxaparina/efeitos adversos; Enoxaparina/análogos & derivados; Voluntários Saudáveis; Heparina de Baixo Peso Molecular; Humanos; Masculino; Ensaios Clínicos Controlados Aleatórios como Assunto; Equivalência Terapêutica

Palavras-chave

anticoagulant; antithrombotic; bioequivalence; enoxaparin; heparin; low-molecular-weight-heparin; pharmacodynamic equivalence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enoxaparina / Medicamentos Biossimilares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enoxaparina / Medicamentos Biossimilares Idioma: En Ano de publicação: 2022 Tipo de documento: Article